Newsletter | January 7, 2021

01.07.21 -- Reasons CDMOs Lose Bids

 
Reasons CDMOs Lose Bioprocessing Bids
 

In Q2 2020, ISR asked 100 respondents who outsource bioprocessing what is the main reason a CDMO may lose the bid for an outsourced bioprocessing project. Regulatory violations/FDA form 483 warnings topped the list, capturing 32 percent of respondents’ votes.

Reasons CDMOs Lose Oral Dose Manufacturing Bids
 

In Q2 2019, ISR asked 101 respondents who outsource oral dose drug product manufacturing what is the main reason a CDMO may lose the bid for an outsourced manufacturing project. Regulatory violations/FDA form 483 warnings topped the list, capturing 30 percent of respondents’ votes.

Reasons CDMOs Lose Sterile Injectable Manufacturing Bids
 

In Q2 2019, ISR asked 101 respondents who outsource sterile injectable drug product manufacturing what is the main reason a CDMO may lose the bid for an outsourced manufacturing project. Regulatory violations/FDA form 483 warnings topped the list, capturing 25 percent of respondents’ votes.

6 Reasons You Don’t Use Pharmaceutical Market Research
 

If you're using one of these six excuses for ignoring pharma market research, you're failing to understand barriers to success, missing the market’s perspective, and leaving assumptions unvalidated.